The establishment of decidualization is a prerequisite of successful pregnancy. Lysyl oxidase (Lox) is a copper-containing amine oxidase which catalyzes cross-linking of collagen and elastin in the ECM. Lox is expressed in the subluminal stroma surrounding the implanting blastocyst on day 5 of pregnancy. From days 6 to 8, the signals for Lox mRNA and protein are strongly detected in the decidual cells. The expression of Lox is under the control of estrogen via the GSK-3b/b-catenin/c-myc pathway. Dtprp is decreased by the inhibition of Lox activity. Furthermore, the inhibition of Lox activity decreases stromal cell migration and embryo adhesion. Our findings highlight the crucial role of Lox in endometrial stromal cells and deepen our understanding of decidualization.
The establishment of decidualization is a prerequisite of successful pregnancy. Lysyl oxidase (Lox) is a copper-containing amine oxidase which catalyzes cross-linking of collagen and elastin in the ECM. Lox is expressed in the subluminal stroma surrounding the implanting blastocyst on day 5 of pregnancy. From days 6 to 8, the signals for Lox mRNA and protein are strongly detected in the decidual cells. The expression of Lox is under the control of estrogen via the GSK-3b/b-catenin/c-myc pathway. Dtprp is decreased by the inhibition of Lox activity. Furthermore, the inhibition of Lox activity decreases stromal cell migration and embryo adhesion. Our findings highlight the crucial role of Lox in endometrial stromal cells and deepen our understanding of decidualization.
Keywords: decidualization; Lox; uterus Implantation is an imperative process for successful pregnancy. Following implantation, stromal cells differentiate to decidual cells along with extracellular matrix (ECM) remodeling [1] . The ECM provides a structural frame for moving cell and thereby affects cell adhesion and migration. ECM secreted by decidual cells is composed of collagenous and noncollagenous proteins, such as elastin, fibronectin, laminin, and heparin sulfate proteoglycans [2] . Collagens are the principal structural elements of ECM that contribute to stiffness of the ECM [3] . Study in tumor cells shows that collagen crosslinking drives ECM stiffening and leads to advanced cell adhesion and migration [4] . Information concerning the remodeling mechanism of ECM during decidualization is still unclear.
Lysyl oxidase (Lox) is a secreted ECM modifying enzyme. The production of the mature form of Lox includes multiple steps. Initially, Lox is synthesized as a pre-pro-protein. Then the pre-pro-Lox undergoes intracellular post-translational modifications to form pro-Lox. Pro-Lox is secreted to the extracellular space where it is cleaved by bone morphogenetic protein-1 (Bmp1) to release the catalytically active mature Lox and the Lox propeptide [5] . The best-characterized role of Lox is remodeling ECM through the oxidative deamination of peptidyl lysine residues between collagens and/or elastin to facilitate covalent cross-link [6] . The cross-link among ECM components enhances matrix stiffness [7] . Previous report implicates Loxmediated collagen crosslinking as a contributor to ECM stiffening, which leads to enhanced invasive behavior of tumors [8] . However, the role of collagen crosslinking has not been determined during decidualization.
Here, we assessed the expression, regulation, and biological functions of Lox in endometrial stromal cells Abbreviations BAPN, b-Aminopropionitrile; Bmp1, bone morphogenetic protein-1; ECM, extracellular matrix; LiCl, lithium chloride; Lox, Lysyl oxidase; PPT, propyl pyrazole triol; WT, wild-type. during decidualization. Lox expression is specifically localized in the decidual cells and increased during the progress of decidualization. The expression of Lox is under the control of estrogen. GSK-3b/b-catenin/c-Myc signaling pathway plays an important role in the regulation of Lox expression in stromal cells during decidualization. The upregulation of Lox during decidualization suggests the importance of collagen crosslinking. Inhibition of Lox activity affects the process of decidualization of endometrial stromal cells. Furthermore, the adhesion of embryos and cell migration are also impeded by Lox activity inhibitor.
Methods

Animals and treatments
Mouse (CD-1 strain) were housed in an animal room with a controlled environment (22-24°C and 60-70% relative humidity) and maintained on a light/dark cycle (12 h light/ 12 h dark). All animal procedures were approved by the Animal Care and Use Committee of South China Agricultural University. Female mice were mated with fertile or vasectomized male mice in the afternoon to induce pregnancy or pseudopregnancy. The day when vaginal plug was detected was defined as day 1 of pregnancy. Pregnancy on days 1-4 was confirmed by recovering embryos from the oviduct. The implantation sites on day 5 were identified after intravenous injection of Chicago Blue dye solution.
To induce and maintain delayed implantation, mice were ovariectomized at 08:30-09:00 on day 4 of pregnancy and injected daily with progesterone (P4, 1 mg/0.1 mL sesame oil/mouse; Sigma, Saint Louis, MO, USA) from days 5 to 7. To terminate delayed implantation and to induce blastocyst activation, estradiol-17b (E2, 25 ng/0.1 mL sesame oil/ mouse; Sigma) were given to P4-primed delayed implanting mice on day 7. Mice were killed 24 h after treatment with the respective steroid hormones. The delayed implantation was confirmed by flushing blastocysts from uteri. The activation of delayed implantation was confirmed by visually detectable implantation sites after blue dye injection.
To induce artificial decidualization, sesame oil (10 lL, Sigma) was injected into one uterine horn on day 4 of pseudopregnancy while the noninjected contralateral horn served as a control. Deciduoma was observed on day 8 of pseudopregnancy. An irreversible inhibitor for Lox, b-aminopropionitrile (BAPN, 1 mg/5 µL/mouse, dissolved in saline; Sigma, A3134), was infused into one uterine horn 5 min before the injection of sesame oil. Saline was injected with the same volume as a control.
Based on previous studies [9] , BAPN (100 mgÁkg À1 , dissolved in saline, injection volume is 100 lL per mouse) was daily injected intraperitoneally into pregnant mice at 22:00 on day 4 and 10:00 on day 5. Saline treatment with the same injection volume was served as a control. Uteri were collected on day 8 and record the weight of implantation sites. Embryos were dissected from the implantation sites to measure the weight of decidual tissue. To determine effects of steroid hormones 2 weeks after ovariectomy, mice were treated with a single injection of estradiol-17b (100 ng per mouse), P4 (1 mg per mouse), propyl pyrazole triol (PPT, 250 ng per mouse; Sigma), a selective ERa agonist, or diarylpropionitrile (DPN, 100 ng per mouse; Sigma), a selective ERb agonist. To further confirm whether Lox expression was ERa-dependent, wild-type (WT), or ERa knock-out (ERaKO) mice were rested for 2 weeks after ovariectomy and then treated with an injected of estrogen. Uteri were collected at 24 h after injection.
RNA extraction and real-time PCR
Tissues were collected and stored immediately at À70°C. Total RNAs were isolated using a standard TRI Reagent (Sigma)-based protocol according to the manufacturer's instructions, followed by quantification and a quality assessment. In addition, cDNA was synthesized using the PrimeScript reverse transcriptase reagent kit (Perfect Real Time, TaKaRa, Mountain View, CA, USA) according to the manufacturer's directions. The conditions used for real-time PCR were as follows: 95°C for 10 s followed by 39 cycles of 95°C for 5 s and 60°C for 34 s. All reactions were run in triplicate. Rpl7 was used for normalization. Data from realtime PCR were analyzed using the 2MMCt method. Primers used for real-time PCR were listed in Table 1 .
In situ hybridization
Total RNAs were isolated from mouse uteri on day 8 of pregnancy, reverse transcribed, and amplified with the primers for mouse Lox and Bmp1. The amplified fragment of each gene was cloned into pGEM-T plasmid and verified by sequencing. To prepare the templates, the plasmids were amplified with the primers for T7 and SP6. Digoxigeninlabeled antisense or sense cRNA probes were transcribed in vitro using a digoxigenin RNA labeling kit (Roche Applied Science, San Francisco, CA, USA) according to the manufacturer's instructions. Primers used for in situ hybridization were listed in Table 1 .
Frozen uterine sections (10 lm) were mounted onto 3-aminopropyltriethoxysilane (Sigma)-coated slides and fixed in 4% paraformaldehyde solution in PBS for 1 h. Hybridization was performed at 55°C for 16 h. Then sections were incubated in anti-digoxigenin antibody conjugated with alkaline phosphatase (1:5000; Roche Applied Science). The positive signal was visualized with the buffer containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate (Amresco, Solon, OH, USA) and 0.4 mM nitro blue tetrazolium (Amresco) as a dark brown color. All of the sections were counterstained with 1% methyl green. Digoxigenin-labeled sense probe for each gene was also hybridized and served as negative control. Endogenous alkaline phosphatase activity was inhibited with 2 mM levamisole (Sigma).
Isolation and treatment of endometrial stromal cells
Mouse endometrial stromal cells were isolated as previously described [10] . Briefly, uteri collected from female mice on day 4 of pregnancy were cut open and digested with 1% (w/v) trypsin (Amresco) and 6 mgÁmL À1 dispase (Roche Applied Science) in HBSS for 1 h at 4°C followed by 1 h at room temperature and 10 min at 37°C to remove luminal epithelial cells. The remaining pieces of tissues were incubated in HBSS containing 0.15 mgÁmL À1 collagenase I (Invitrogen, Houston, TX, USA) at 37°C for 30 min, followed by vigorously shaking until supernatants became turbid. The supernatants were filtrated through 70-lm wire gauze and centrifuged to collect the stromal cells. The isolated cells were grown in DMEM/F-12 medium with 10% charcoal-treated fetal bovine serum (CFBS; Invitrogen). The medium was changed to remove unattached cells after an initial culture for 30 min and allowed to attach overnight. To induce decidualization in vitro, mouse endometrial stromal cells were treated with 10 nM of estradiol-17b plus 1 lM of progesterone for 72 h. To examine the effects of estrogen secreted in decidua, cells were treated with letrozole. For further studies, the cells were treated with 10058-F4 (20 lM, Sigma), CTT036477 (5 lM, Calbiochem, Houston, TX, USA), or Lithium chloride (20 lM, Sigma).
Subcellular fractionation and western blot
Subcellular fractionation was used to isolate nuclei as previously described [11] . Briefly, uteri or cells were collected in PBS containing 5 mM EDTA. Nuclear fractions were extracted using nuclear buffer (20 mM HEPES, pH 7.5, 1.5 mM MgCl 2 , 0.5 mM DTT, 420 mM NaCl, 1 mM NaF, and 1 mM glycerol phosphate). The whole cellular or extracted nuclear samples were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4), 150 mM NaCl, 5 mM EDTA, 10 mM NaF, 1 mM Na 3 VO 3 , 1% Sodium deoxycholate, 1% Triton X-100, and 0.1% SDS) with complete protease inhibitor cocktail (Roche Applied Science). Protein concentration was measured by BCA Reagent kit (Thermo, Houston, TX, USA). Samples were then resolved on a 10% SDS/ PAGE gel and transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, San Francisco, CA, USA). After blocking in 5% nonfat dry milk (Sangon, Shanghai, China) for 1 h at room temperature, membranes were probed with the corresponding primary antibodies overnight at 4°C. After washing, membranes were then incubated with matched secondary antibodies conjugate with horseradish peroxidase for 1 h in room temperature and visualized using ECL chemiluminescent kit (Pierce, San Francisco, CA, USA). The blots were scanned by Canon MP Navigator EX (CanoScan LiDE 700F, Canon, Japan). The primary antibodies used were as follows: anti-Lox (66948, Santa Cruz, Santa Cruz, CA, USA), anti-c-MYC (9402s, Cell Signaling, New York, NY, USA), anti-GSK3b (9315, Cell Signaling), anti-b-catenin (4270s, Cell Signaling), anti-b-actin (4970s, Cell Signaling), and anti-Bmp1 (33200, Santa Cruz). b-actin is as internal control and Lamin A/C is as nucleus control.
Immunohistochemistry
Paraffin-embedded uterine sections (5 lm thick) were deparaffinized in xylene, rehydrated through a graded series of ethanol, and washed in water. Antigen retrieval was performed in 10 mM sodium citrate buffer (pH 6.0) by microwaving for 10 min and then the buffer was cooled to room temperature. Endogenous horseradish peroxidase (HRP) activity was inhibited with 3% H 2 O 2 for 15 min. After blocked with 10% horse serum at 37°C for 1 h to prevent 
Immunofluorescence
Frozen sections were fixed in 4% paraformaldehyde diluted in PBS for 15 min at 4°C and washed three times in PBS.
After treated with 0.1% Triton X-100 in PBS for 20 min, sections were blocked with 5% donkey serum for 1 h at 37°C, and then incubated with anti-Lox antibody (1:50, Santa Cruz) for overnight at 4°C. After washing in PBS, sections were incubated with FITC-conjugated secondary antibody for 30 min at 37°C and counterstained with 4, 6-diamidino-2-phenylindole dihydrochloride (DAPI) for nuclei. The fluorescent signals were examined under a fluorescence microscopy. Negative control slides were immunolabeled with anti-GFP antibody (Santa Cruz).
Alkaline phosphatase activity
Frozen uterine sections were fixed with 4% paraformaldehyde in PBS for 15 min at 4°C, and washed with 1x PBS three times for 5 min each. The uterine sections were then incubated at room temperature in a solution containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate (Amresco) and 0.4 mM nitro blue tetrazolium (Amresco) in 0.1 M TrisHCl, 0.1 M NaCl, and 0.05 M MgCl 2 , pH 9.5.
Embryo outgrowth assay
Blastocysts were flushed from the uterine horns at 16:00 on day 4 of pregnancy and cocultured with primary stromal cells in the presence or absence of BAPN. Blastocyst outgrowth was examined at 48 h and 72 h of culture. The outgrowth area was calculated by IMAGEJ software [12] .
Results
Expression of Lox and Bmp1 in mouse uterus during early pregnancy
In situ hybridization and immunofluorescence were conducted to examine the localization of Lox in mouse uterus during decidualization. From days 1 to 4, no signal for Lox mRNA or protein was detected in mouse uterus. On day 5, the signals for Lox mRNA and protein were first detected in the subluminal stroma surrounding the implanting blastocyst at implantation sites while no signal was observed at interimplantation sites (Fig. 1 ). From days 6 to 8, the signals for Lox mRNA and protein were strongly detected in the decidual cells surrounding embryos (Fig. 1) . There was no specific signal for Lox mRNA or protein with a sense Lox probe or anti-GFP antibody, respectively (Fig. 1) . The cleavage of Lox proenzyme by bone morphogenetic protein-1 (Bmp-1) is essential for the activation of its oxidase activity [13] . We then analyzed the expressions of Bmp1 in mouse uteri on days 5-8 by in situ hybridization. The expression pattern of Bmp1 mRNA was similar to Lox in decidual cells (Fig. 2A) . And Bmp1 protein expression detected by western blot was up-regulated from days 5 to 8 (Fig. 2B) . These results suggest Bmp1 plays a role in Lox activation. Furthermore, via western blot, pro-Lox (50 kDa) and mature Lox (30 kD) were detected from days 5 to 8. Both pro-Lox and Lox protein were up-regulated from days 5 to 8 (Fig. 2B) .
To certify whether the expression of Lox is dependent on decidualization that is initiated by implantation, we examined the expression of Lox during pseudopregnancy. No signal for Lox mRNA and protein was detected in mouse uteri from days 1 to 5 of pseudopregnancy (Fig. 2C) . A delayed implantation model was used to further check whether the expression of Lox was induced by decidualization initiated by implantation. There was no detectable signal for Lox in mouse uteri under delayed implantation (Fig. 2C) . After delayed implantation was activated by estrogen treatment, the signals for Lox mRNA and protein expression were highly detected in the primary decidual zone surrounding the implanting embryo (Fig. 2C) . To further analyze whether the expression of Lox was dependent on decidualization, an artificial decidualization model was performed. The expression of Lox was detected under artificial decidualization but not in the control uterine section (Fig. 2C) .
Function of Lox during decidualization
To study the function of Lox during decidualization, we first examined the expression of Lox during in vitro decidualization induced by combination of estrogen and progesterone. Lox mRNA expression increased at 72 h after hormonal treatment (Fig. 3A) . Dtprp, a marker for mouse decidualization, was also induced (Fig. 3B) . As Lox expression in mouse uterus was under the control of estrogen which is reported to be de novo produced during decidualization [14] , stromal cells were treated with letrozole (an aromatase inhibitor) to block estrogen producing. The expression of Lox mRNA in stromal cells was blocked by combinating estrogen, progesterone, and letrozole while combination of estrogen and progesterone induced Lox mRNA expression in stromal cells (Fig. 3C) . Letrozole did not affect Lox mRNA expression alone (Fig. 3C) . Western blot results further showed that Lox protein level was reduced in letrozole-treated cells (Fig. 3D) . These results indicated the involvement of estrogen in Lox expression during decidualization.
To further study the role of Lox during decidualization, b-Aminopropionitrile (BAPN), an inhibitor of Lox activity [9] , was used during decidualization both in vivo and in vitro. In pregnant mice, BAPN (100 mgÁkg À1 ) administration did not affect body weight of mice and number of implantation sites (Figs 2 and 4) but reduced the size and weight of implantation sites and weight of decidua on day 8 during early pregnancy (Fig. 4A,B) . Then we performed artificial decidualization in pseudopregnant mice to further confirm the result. Mice were treated with BAPN (0.1 mg per 5 lL) by intrauterine injection on day 4 of pseudopregnancy before intrauterine oil injection. Compared with saline injection, BAPN inhibited Lox activity resulting affecting crosslink of collagen (Fig. 5) , and significantly reduced the size and weight of deciduoma (Fig. 4C,D) . Alkaline phosphatase staining showed that the activity of alkaline phosphatase, Fig. 1 . Lysyl oxidase is induced in the uterus during early pregnancy. Both mRNA and protein localizations of Lox in mouse uterus from day 1 (D1) to day 8 (D8) during early pregnancy were detected by in situ hybridization and immunostaining. Interimplantation site on day 5 pregnancy mice was also used to detect the mRNA and protein of Lox by in situ hybridization and immunostaining. The negative controls by using sense Lox probe and GFP were also shown. At least three mice were used for each experiment. Bar, 300 µM; IS, implantation site; NIS, interimplantation site.
the marker of decidualization, was reduced by BAPN in artificial decidualization frozen sections (Fig. 4E) . During in vivo decidualization induced by estrogen (10 nM) and progesterone (1 lM), the expression of Dtprp was decreased by BAPN combined, while no changes in Dtprp expression was observed under BAPN treatment alone (Fig. 4F) . These results suggested the critical role of Lox in decidualization.
Lox promotes blastocyst outgrowth and migration of stromal cells
Given that Lox-mediated collagen crosslinking acts as a contributor to invasive behavior of tumors [8] , we investigated whether Lox participated in blastocyst outgrowth. Blastocyst outgrowth was checked at 48 h and 72 h after coculture. Compared with the control, the outgrowth of embryos was inhibited by BAPN (Fig. 5A,B) . These results demonstrated the critical role of Lox in blastocyst invasion. A previous study reported that Lox involves in tumor cell migration [4] . This prompted us to study the function of Lox in the migration of stromal cells. Cultured stromal cells were scratched with micropipette tips and then treated with BAPN. Control cells migrated to fill up the gap at about 72 h. However, BAPN-treated cells migrated much slower than control group (Fig. 6A,B) . This result suggested that Lox regulates the migration ability of stromal cells.
Effects of estrogen on Lox expression in mouse uterus
To study the regulation of hormones on Lox expression, ovariectomized mouse were treated with estrogen (100 ng per mouse) and progesterone (1 mg per mouse), respectively. Real-time PCR results showed that estrogen enhanced Lox mRNA expression, whereas progesterone was unable to induce Lox expression but reduced the Lox mRNA expression (Fig. 7A) . A combination of estrogen and progesterone injection did not affect Lox expression (Fig. 7A) . Western blot results showed that Lox protein level was also upregulated by estrogen and reduced by progesterone (Fig. 7B) . PPT-induced Lox mRNA expression and DPN did not affect Lox mRNA expression, suggesting ERa involvement in estrogen regulation on Lox (Fig. 7C) . To further confirm the role of ERa, estrogen treatment was performed in WT or ERa knockout (ERaKO) mice. Lox mRNA expression level was significantly induced in WT mice, while no obvious change was detected in ERaKO mice (Fig. 7D) . These results indicated the importance of ERa in mediating estrogen action on Lox expression.
Expression and regulation of GSK-3b/b-catenin/cMyc pathway in mouse uterus
The results of promoter analysis showed c-Myc-binding sites in the Lox promoter region. Previous study has shown c-Myc regulation by estrogen in mouse uterus [15] . c-Myc is the downstream of GSK-3b/bcatenin pathway in previous studies [12] . Taken together, we assumed that GSK-3b/b-Catenin/c-Myc might involve in the mediation of estrogen in Lox expression. To test this hypothesis, we first examined the localization of GSK-3b and b-catenin during early pregnancy. From days 5 to 8, the signals for GSK-3b and b-catenin protein were strongly detected in decidual cells (Fig. 8A,B) . Western blot results showed the upregualtion of GSK-3b/b-catenin/c-Myc pathway in mouse uteri on days 5-8 (Fig. 8C) . We then explored the effects of estrogen on GSK-3b/b-catenin/c-Myc pathway in ovariectomized mouse uterus. Estrogen stimulated notable increases in Gsk-3b and c-Myc protein levels while the expression of b-catenin was decreased (Fig. 8D) . These results revealed estrogen could activate the GSK-3b/b-catenin/c-Myc pathway in mouse uterus.
GSK-3b/b-catenin/c-Myc regulation on Lox in stromal cells
To investigate the regulation of GSK-3b/b-catenin/cMyc pathway on c-Myc and Lox, lithium chloride (LiCl), a GSK-3b inhibitor, was used to analyze the regulation of GSK-3b on c-Myc and Lox in cultured endometrial stromal cells. The expression levels of c-Myc and Lox mRNA and protein were downregulated by LiCl (Fig. 9A,B) . On the other hand, b-catenin inhibitor CTT036477 induced the mRNA and protein levels of c-Myc and Lox (Fig. 9C,D) . To gain insights into the regulation of c-Myc on Lox, stromal cells were treated with 10058-F4, an inhibitor of c-Myc. Both the mRNA and protein levels were decreased by 10058-F4 (Fig. 9E,F) . Furthermore, LiCl-induced b-catenin expression was dramatically blocked by CTT036477. The induction of both c-MYC and Lox expressions by CTT036477 was weakly induced by LiCl treatment, and the expression of Lox was weakly reduced by 10058-F4 plus CTT036477 (Fig. 9G) . These data suggested that GSK-3b/b-catenin/c-MYC signaling pathway contributed to the Lox expression in endometrial stromal cells.
Discussion
Our results in mouse uterus showed specific localization of Lox in the stromal cells surrounding the implanting embryos and the decidual cells during decidualization. High level of Lox expression is observed in the stromal cells in the endometrium of fertile women during WOI [16] . The spatio-temporally specific localization suggests the importance of Lox-induced ECM remodeling during early pregnancy. Our results also showed that estrogen plays a critical role in Lox expression levels. Study in mouse cervix shows that Lox activity is under the control of estrogen and is at the highest level during estrus [17] . Study in vagina shows that estrogen treatment results in increased collagen expression and crosslinking by upregulating Lox [18] . These results are similar to our current results and show the important role of estrogen on Lox. However, a previous study in the uterus during late pregnancy shows that aromatase inhibitor increases Lox expression. As a result, the obstructive uterine tissue framework abnormally increases intrauterine pressure and leads to fetus hematomata on the head [19] . Taken together, Lox expression during early pregnancy may promote embryouterus interaction by regulating uterus contraction through mediating tissue framework. A previous study established the importance of locally produced estrogen in the progress of decidualization [14] . It is, therefore, conceivable that the local estrogen produced in the decidua mediates Lox expression.
The ERa is mainly activated by estrogen to regulate a wide range of cellular activities in response to estrogen [20] . Recent studies have shown that in HA22T cells, ERa binds to GSk-3b and induced ubiquitination and degradation of b-catenin in a ligand-dependent [21, 22] . Our studies show that GSK-3b and c-MYC can be induced by estrogen in ovariectomized mouse while estrogen can reduce nuclear b-catenin expression. It is well established that GSK-3b is required for phosphorylation and subsequent degradation of b-catenin, and c-MYC is a downstream target of b-catenin [23] . In cultured stromal cells, experience indicated that LiCl, an inhibitor of GSK-3b, can reduce the expression of c-MYC and Lox in mouse uterine stromal cells followed. Thus, the activation of Wnt/b-catenin signaling pathway followed by LiCl treatment can down-regulate c-MYC and Lox. As CTT036477 is an inhibitor of b-catenin, we found that inactivation of Wnt/b-catenin signaling pathway had effects on c-MYC and Lox upregulation. Interestingly, in this study, Lox is reduced in mouse uterine stromal cells after 10058f4 treatment. In addition, the result of immunohistochemistry show that GSK-3b is expressed during days 5-8 of pregnancy. And the expression of b-catenin has a colocalization with Lox during days 5-8. In summary, our data show that estrogen stimulation upregulates the expression of Lox through GSK3b/b-catenin/c-MYC signal pathway. Estrogen upregulated GSK-3b leading to degradation of b-catenin, which resulted in increase in c-MYC that can induce Lox. It is reported that c-Myc is strongly expressed in mouse uterus decidual cells on days 5-8 during early pregnancy and both estrogen and progesterone play roles in c-Myc expression regulating [15] . In NIH 3T3 cells, increased expression of Lox leads to a dosedependent decrease in c-Myc expression through regulating NFkB binding and activity [24] . These results imply that there might be negative feedback between c-Myc and Lox.
Lox is secreted as pro-Lox protein and undergoes proteolytic processing by Bmp1 to form mature Lox enzyme and propeptide (Lox-PP). Several Bmp family members are essential for mouse decidualization [25] . BMP2 deficiency leads to the failure of decidualization [26] . However, BMP-1 is erroneously considered as a member of the BMP subfamily, but has no homology with the other BMP proteins. BMP-1 converts precursor proproteins into mature functional proteins. After pro-Lox is secreted into the extracellular space, it is cleaved by Bmp1 to form active mature Lox [5] . Our in situ hybridization results showed a colocalization of Bmp1 and Lox in mouse uterus during decidualization.
The best-characterized role of Lox is ECM remodeling through the oxidative deamination of lysine residues between collagens and/or elastin to facilitate covalent cross-linking, thereby enhancing the ECM stiffness [6] . As the major components of decidual ECM, collagen is produced by decidual cells [27] and remodels during decidualization [11] . During implantation, the interactions between the invading embryo and decidual ECM are important for pregnancy outcome. It has been demonstrated that Lox-related ECM stiffness involves in tumor cell migration [4] . The stromal cells migration was affected by Lox activity inhibitor BAPN. The observations are consistent with the functional role of Lox in cancer cell migration. Decidualization is accompanied by metalloproteinases (MMP)-dependent ECM degradation. MMP-2 and MMP-9 are defined to induce trophoblast invasion and play crucial roles in human implantation [28] . Besides MMPs, a disintegrin and metalloproteinase (ADAM) family member ADAM12 and ADAMTS also plays a critical role in the regulation of trophoblast invasion [29, 30] . Taken together, as the crosslinking and degradation enzymes all play critical roles during decidualization, the balanced collaboration among these enzymes might provide the dynamic environment for embryo adhesion and development in different phases during pregnancy.
Altogether our study has taken steps to increase the current knowledge of Lox expression, regulation, and function during decidualization. As Lox knockout mice die just before or soon after birth as a result of severe cardiovascular malformation [31], it will be essential to develop a conditional knockout model of Lox in uterus to increase our understanding of the role of Lox during pregnancy. As a secreted molecule, Lox has been validated as a clinical prognostic marker for cancer [5] . It raises the possibility that Lox may serve as a marker for implantation. In addition, Lox might serve as a potential target for contraception. For the clinical need to develop therapies against secondary metastatic cancer, Lox has been considered as a target for cancer metastasis [32] . Endometrium-related diseases such as endometriosis and carcinoma are estrogen dependent. As Lox is under the control of estrogen, it might be a therapeutic target for these diseases. Taken together, our data offer a new paradigm for understanding the role of Lox-induced ECM remodeling during early pregnancy and suggests that Lox may serve as a potential marker for implantation and target for therapies in pregnancyrelated diseases. 
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